Pfizer Names New General Counsel
NEW YORK (Reuters) - Pfizer Inc <PFE.N> on Wednesday named
Amy Schulman, who has led litigation efforts for the drugmaker
involving its painkillers Celebrex and Bextra, as its general
counsel.
NEW YORK (Reuters) - Pfizer Inc <PFE.N> on Wednesday named
Amy Schulman, who has led litigation efforts for the drugmaker
involving its painkillers Celebrex and Bextra, as its general
counsel.
Similar/Related/News: